PL1660462T3 - Pochodne 8-chloro-2,3-benzodiazepiny - Google Patents

Pochodne 8-chloro-2,3-benzodiazepiny

Info

Publication number
PL1660462T3
PL1660462T3 PL04769081T PL04769081T PL1660462T3 PL 1660462 T3 PL1660462 T3 PL 1660462T3 PL 04769081 T PL04769081 T PL 04769081T PL 04769081 T PL04769081 T PL 04769081T PL 1660462 T3 PL1660462 T3 PL 1660462T3
Authority
PL
Poland
Prior art keywords
chloro
benzodiazepine derivatives
new
stands
preparation
Prior art date
Application number
PL04769081T
Other languages
English (en)
Inventor
Jozsef Barkoczy
István Ling
Gyula Simig
Gábor Szénási
Gábor Gigler
Szabolcs Kertész
Gyula Szücs
Géza Szabó
Miklós Végh
László Gábor Hársing
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of PL1660462T3 publication Critical patent/PL1660462T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL04769081T 2003-08-04 2004-07-29 Pochodne 8-chloro-2,3-benzodiazepiny PL1660462T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0302449A HUP0302449A3 (en) 2003-08-04 2003-08-04 8-chloro-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for producing them
EP04769081A EP1660462B1 (en) 2003-08-04 2004-07-29 8-chloro-2,3-benzodiazepine derivatives
PCT/HU2004/000082 WO2005012265A1 (en) 2003-08-04 2004-07-29 8-chloro-2,3-benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
PL1660462T3 true PL1660462T3 (pl) 2009-07-31

Family

ID=89981556

Family Applications (2)

Application Number Title Priority Date Filing Date
PL379245A PL379245A1 (pl) 2003-08-04 2004-07-29 Pochodne 8-chloro-2,3-benzodiazepiny
PL04769081T PL1660462T3 (pl) 2003-08-04 2004-07-29 Pochodne 8-chloro-2,3-benzodiazepiny

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL379245A PL379245A1 (pl) 2003-08-04 2004-07-29 Pochodne 8-chloro-2,3-benzodiazepiny

Country Status (23)

Country Link
US (1) US7960375B2 (pl)
EP (1) EP1660462B1 (pl)
JP (1) JP4752011B2 (pl)
KR (1) KR20060120578A (pl)
CN (1) CN100551915C (pl)
AT (1) ATE414695T1 (pl)
AU (1) AU2004261491B2 (pl)
BG (1) BG109462A (pl)
CA (1) CA2534458A1 (pl)
CZ (1) CZ2006131A3 (pl)
DE (1) DE602004017878D1 (pl)
DK (1) DK1660462T3 (pl)
EA (1) EA009373B1 (pl)
ES (1) ES2317038T3 (pl)
HU (1) HUP0302449A3 (pl)
IL (1) IL173476A (pl)
PL (2) PL379245A1 (pl)
PT (1) PT1660462E (pl)
SI (1) SI1660462T1 (pl)
SK (1) SK50212006A3 (pl)
UA (1) UA84159C2 (pl)
WO (1) WO2005012265A1 (pl)
ZA (1) ZA200601698B (pl)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179018B (en) * 1978-10-19 1982-08-28 Gyogyszerkutato Intezet Process for producing new 5h-2,3-benzodiazepine derivatives
HU191702B (en) 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU195788B (en) * 1986-05-21 1988-07-28 Gyogyszerkutato Intezet Process for producing 1-/hydroxy-stiryl/-5h-2,3-benzobiazepines and pharmaceutical compositions containing them
HU206719B (en) 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
DE19604920A1 (de) * 1996-02-01 1997-08-07 Schering Ag Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
HU9600871D0 (en) * 1996-04-04 1996-05-28 Gyogyszerkutato Intezet New 2,3-benzodiazepine derivatives
HU225100B1 (hu) * 2000-12-21 2006-06-28 Egyt Gyogyszervegyeszeti Gyar 2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk

Also Published As

Publication number Publication date
EA200600373A1 (ru) 2006-08-25
SK50212006A3 (sk) 2006-08-03
BG109462A (en) 2006-11-30
IL173476A0 (en) 2006-06-11
AU2004261491A1 (en) 2005-02-10
HUP0302449A3 (en) 2005-06-28
SI1660462T1 (sl) 2009-04-30
HUP0302449A2 (hu) 2005-04-28
WO2005012265A1 (en) 2005-02-10
JP4752011B2 (ja) 2011-08-17
ES2317038T3 (es) 2009-04-16
US20080153814A1 (en) 2008-06-26
US7960375B2 (en) 2011-06-14
CA2534458A1 (en) 2005-02-10
CZ2006131A3 (cs) 2006-12-13
KR20060120578A (ko) 2006-11-27
DK1660462T3 (da) 2009-03-16
HU0302449D0 (en) 2003-10-28
AU2004261491B2 (en) 2009-12-17
EA009373B1 (ru) 2007-12-28
CN1871223A (zh) 2006-11-29
EP1660462A1 (en) 2006-05-31
PL379245A1 (pl) 2006-08-07
IL173476A (en) 2013-01-31
JP2007501216A (ja) 2007-01-25
CN100551915C (zh) 2009-10-21
PT1660462E (pt) 2009-02-20
UA84159C2 (en) 2008-09-25
DE602004017878D1 (de) 2009-01-02
EP1660462B1 (en) 2008-11-19
ZA200601698B (en) 2007-05-30
ATE414695T1 (de) 2008-12-15

Similar Documents

Publication Publication Date Title
YU68102A (sh) Derivati karboksilne kiseline kao ip antagonisti
HRP20040686B1 (hr) Novi heterocikliäśki spojevi koji djeluju kao inhibitori beta-laktamaza
YU52403A (sh) Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
WO2006024486A3 (en) Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
MY140057A (en) Novel heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine
PE20030257A1 (es) Analogos de 8-aza-11-desoxi-prostaglandina como agonistas del receptor ep4
WO2007084914A3 (en) Phenoxy-substituted pyrimidines as adenosine receptor antagonists
IL217446A (en) Pharmaceutical preparation containing a highly purified active ingredient of 7 - chloro - 5 - hydroxy - 1 - [2 - methyl - 4 - (2 - methylbenzoyl - amino) benzoyl] - 2, 3, 4, 5 - tetrahydro - h - 1 - Benzazepine has a purity of more than 99.5% or its salt, or a drug of its salt
MXPA04005209A (es) Antagonistas del receptor de adenosina a2a.
MX347706B (es) Derivados de triazol y su uso para trastornos neurologicos.
SE0400284D0 (sv) Novel compounds
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
AP1522A (en) Compounds having hypolipedemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them.
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
WO2001090097A3 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
IL148975A0 (en) Novel cyclopropanes as cprp antagonists, medicaments containing said compounds and method for the production thereof
YU53100A (sh) Derivati 2-ariletil-(piperidin-4-ilmetil)amina kao antagonisti muskarinskih receptora
TNSN07006A1 (en) Novel heterocyclic compounds
MXPA04005426A (es) Derivados de pirazol de anillos fuisionados.
BG106044A (en) Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
PT1234818E (pt) Sais de calcio de derivados de 1,5-benzodiazepina, processo para producao dos sais e drogas que os contem
SG146627A1 (en) Imidazole derivatives
HU0302449D0 (en) 8-chloro-2,3-benzodiazepine deivatives
WO2002062798A3 (en) Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
MX2007011280A (es) Dipirazoles como farmacos del sistema nervioso central.